Piramal Phytocare (Delisted) share news and announcements
BSE: 532979
Formerly Piramal Life Sciences
Last traded ₹22.70 on 10 Dec 2019
Delisted on 27 May 2020.
Piramal Phytocare share news and announcements
488 announcements, routine notices left out, newest first. Page 9 of 10.
Aug 2011
Jul 2011
29 Jul · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 1st Quarter ended June 30, 2011.
Jun 2011
15 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from August 02, 2011 to August 09, 2011 (both days inclusive) ....
May 2011
6 May · Board meeting
At its meeting held on May 6, 2011, the Board considered and approved the Scheme of Arrangement between Piramal Life Sciences Limited (`PLSL') and Piramal Healthcare Limited ('PHL') (`Demerger Scheme'). Under the proposed Demerger Scheme, the New Chemical Entity (NCE) Research Unit would be transferred from PLSL to PHL with effect from April 1, 2011, which is the Appointed Date under the Demerger Scheme. The following exchange ratio has been approved: "1 [one] fully paid up equity shares of Rs. 2/- of PHL shall be issued and allotted for every 4 [four] equity shares of Rs.10 each held in PLSL". The Demerger Scheme is subject to the consent of requisite majority of shareholders and creditors of both PLSL and PHL, sanction of the High Court of Judicature at Bombay and all other regulatory approvals as may be necessary for the implementation of the Demerger Scheme.6 May · Board meeting
Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, considered and approved the Scheme of Arrangement ....4 May · Board meeting
For considering a proposal for Demerger of the New Chemical Entity (NCE) Research Unit of the Company into Piramal Healthcare Limited.4 May · Board Meeting on May 06, 2011
Meeting of the Board of Directors of the Company will be held on May 06, 2011, for considering a proposal for Demerger of the New Chemical ....
Apr 2011
21 Apr · Board meeting
To approve the audited financial results of the Company for the financial year ended on March 31, 2011.
Mar 2011
21 Mar · News Verification
News Verification : The media had reports that Piramal Life Sciences Limited. may merge with Piramal Healthcare Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Piramal Life Sciences Limited has vide its letter inter-alia stated," We would like to state that the Company explores various strategic moves from time to time. However, as a policy and in the interest of its shareholders, the Company does not comment on any report relating to potential strategic initiatives unless they have reached the definite stage. In this context, we would like to inform that the Board of Directors of the Company has not considered any proposal for merger of the Company with Piramal Healthcare Limited. Further, the Company constantly reviews research deals in the ordinary course of business. In the Company's view, there is no such research deal presently being reviewed which is extraordinary. Also, M/s Paramount Pharma Private Limited, a company belonging to the Promoter Group, has vide its letter dated March 11,2011 informed BSE and NSE of its intention to acquire shares of the Company by way of inter-se transfers between and amongst the Promoter group only which would not result in any increase in the overall shareholding of the Promoter Group."21 Mar · Legal
With reference to the news item appearing in a leading financial daily titled "Piramal Life rises 35% in 2 days on rumors of merger, new deal", Piramal Life Sciences Ltd has clarified to ....
Feb 2011
17 Feb · Limited Review for the quarter ended Dec 31, 2010
Jan 2011
25 Jan · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 3rd Quarter ended December 31, 2010.
Nov 2010
18 Nov · Limited Review for the quarter ended Sep 30, 2010
Oct 2010
14 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 2nd Quarter and Half Year ended September 30, 2010.
Sep 2010
20 Sep · Piramal Life Sciences initiates Phase II Trials for P1736-05 for Type II Diabetes in India and Europe
Aug 2010
20 Aug · Limited Review for the quarter ended Jun 30, 2010
Jul 2010
22 Jul · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 1st quarter ended June 30, 2010.